P&K Skin Research Center Co (XKRX:347740) EV-to-EBIT : 7.95 (As of May. 13, 2024)

View and export this data going back to 2020. Start your Free Trial

What is P&K Skin Research Center Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, P&K Skin Research Center Co's Enterprise Value is ₩42,865 Mil. P&K Skin Research Center Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩5,390 Mil. Therefore, P&K Skin Research Center Co's EV-to-EBIT for today is 7.95.

The historical rank and industry rank for P&K Skin Research Center Co's EV-to-EBIT or its related term are showing as below:

XKRX:347740' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.49 Med: 11.89 Max: 102.26
Current: 7.95

During the past 7 years, the highest EV-to-EBIT of P&K Skin Research Center Co was 102.26. The lowest was 3.49. And the median was 11.89.

XKRX:347740's EV-to-EBIT is ranked better than
79.25% of 106 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.34 vs XKRX:347740: 7.95

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. P&K Skin Research Center Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩29,843 Mil. P&K Skin Research Center Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩5,390 Mil. P&K Skin Research Center Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 18.06%.

P&K Skin Research Center Co EV-to-EBIT Historical Data

The historical data trend for P&K Skin Research Center Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

P&K Skin Research Center Co EV-to-EBIT Chart

P&K Skin Research Center Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

15.37

11.07

4.18

5.54

P&K Skin Research Center Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															4.18	7.72	6.16	5.31	5.54

Competitive Comparison of P&K Skin Research Center Co's EV-to-EBIT

For the Diagnostics & Research subindustry, P&K Skin Research Center Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

P&K Skin Research Center Co's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, P&K Skin Research Center Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where P&K Skin Research Center Co's EV-to-EBIT falls into.

P&K Skin Research Center Co EV-to-EBIT Calculation

P&K Skin Research Center Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	42865.339	/	5389.688
	=	7.95

P&K Skin Research Center Co's current Enterprise Value is ₩42,865 Mil.
P&K Skin Research Center Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,390 Mil.

P&K Skin Research Center Co (XKRX:347740) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

P&K Skin Research Center Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	5389.688	/	29842.839
	=	18.06 %

P&K Skin Research Center Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩29,843 Mil.
P&K Skin Research Center Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,390 Mil.

P&K Skin Research Center Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of P&K Skin Research Center Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

P&K Skin Research Center Co (XKRX:347740) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » P&K Skin Research Center Co Ltd (XKRX:347740) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

National Assembly Road 62 -25 Yeongdeungpo-gu, Education Facility Disaster Relief Society Building, 4th Floor, Seoul, KOR, 07236

Website

http://www.pnkskin.com

P&K Skin Research Center Co Ltd is a skin research center. It provides clinical tests for new cosmetics, raw materials, and cosmeceuticals. The company provides skin irritation tests, Stimulation tests, skin wrinkle evaluation, skin texture evaluation, skin whitening evaluation, sweat proof evaluation, skin density measurement, scalp flakiness evaluation, and hair root evaluation. Also, the company provides health food tests, sensory tests, and In Vitro tests.

P&K Skin Research Center Co (XKRX:347740) Headlines

No Headlines